Showing results (121-130 of 232) with videos related to

Sort By:
Pageof 24
Breast Cancer Research and Treatment|May 24, 2023
Vessel size as a marker of survival in estrogen receptor positive breast cancerVladan Milosevic, Reidunn J Edelmann, Ingeborg Winge, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 3, 2013
Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenograftsSiver A Moestue, Else M Huuse, Evita M Lindholm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancerJarle B Arnes, Jean-Sébastien Brunet, Ingunn Stefansson, et al.
Journal of the National Cancer Institute|October 2, 2003
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancerWilliam D Foulkes, Ingunn M Stefansson, Pierre O Chappuis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancerKarin Collett, Geir E Eide, Jarle Arnes, et al.
Langenbeck'S Archives of Surgery|June 20, 2013
Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western NorwayThomas Arnesen, Nina Glomnes, Siri Strømsøy, et al.
Scientific Reports|February 10, 2021
Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancerKristi Krüger, Laxmi Silwal-Pandit, Elisabeth Wik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2021
High PDGFRb Expression Predicts Resistance to Radiotherapy in DCIS within the SweDCIS Randomized TrialCarina Strell, Dick Folkvaljon, Erik Holmberg, et al.
Pageof 24